Biotechnology - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

1 to 25 of 2369 results

Auxilium's supplemental Biologics Application for Xiaflex approved by FDA

Auxilium's supplemental Biologics Application for Xiaflex approved by FDA

21-10-2014

Specialty biopharma company Auxilium Pharmaceuticals has received approval from the US Food And Drug…

Anti-Arthritics/RheumaticsAuxilium PharmaceuticalsBiotechnologyRegulationUSAXiaflex

Eurofins Genomics extends genomic business into Austria and Czech Republic

Eurofins Genomics extends genomic business into Austria and Czech Republic

21-10-2014

Eurofins Genomics, the genomics division of the Eurofins Scientific Group, and international market leader…

AustriaBiotechnologyEurofins GenomicsGeneticsMarkets & Marketing

NewLink Genetics out-licenses NLG919 to Genentech

NewLink Genetics out-licenses NLG919 to Genentech

20-10-2014

US biotech firm NewLink Genetics saw its share price rocket 21.2% in morning trading today, after it…

BiotechnologyGenentechGlobalLicensingNewLink GeneticsNLG919OncologyRoche

ZMapp Ebola medication will improve public understanding of drug production, says Kalorama

ZMapp Ebola medication will improve public understanding of drug production, says Kalorama

20-10-2014

Mapp Biopharma’s ZMapp Ebola therapy will enhance public understanding of the drug development process,…

Antibiotics and Infectious diseasesBiotechnologyMapp BiopharmaceuticalResearchUSAZMapp

Astellas and CoMentis to end Alzheimer’s collaboration

20-10-2014

Japanese drug major Astellas Pharma and US biotech firm CoMentis have said they will end their worldwide…

Astellas PharmaBiotechnologyCoMentisLicensingNeurologicalResearch

Eylea beats Avastin and Lucentis for visual acuity in DME patients

Eylea beats Avastin and Lucentis for visual acuity in DME patients

19-10-2014

US biotech firm Regeneron Pharmaceuticals and partner Germany’s Bayer saw their shares leap 8.5% to…

AvastinBayerBiotechnologyEyleaGenentechLucentisNovartisOphthalmicsRegeneron PharmaceuticalsResearchRoche

Amgen sues Sanofi and Regeneron over alleged patent infringement

19-10-2014

USA-based Amgen has filed a law suit in the US District Court of Delaware against French pharma major…

alirocumabAmgenBiotechnologyCardio-vascularevolocumabLegalPatentsRegeneron PharmaceuticalsSanofiUSA

Profectus BioSciences gets US government funding for Ebola vaccine development

17-10-2014

Under a one-year contract with US biotech firm Profectus BioSciences, the US Department of Health and…

Anti-viralsBiotechnologyFinancialProfectus BioSciencesResearchUSA

Virax to acquire AKTivate and deep AKT inhibitor portfolio

17-10-2014

Australian biotechnology company Virax Holdings will acquire US oncology company AKTivate Therapeutics…

AKTivate TherapeuticsBiotechnologyMergers & AcquisitionsOncologyPathway OncologyVirax Holdings

Selecta, JDRF and Sanofi collaborate to develop SVP for type 1 diabetes

Selecta, JDRF and Sanofi collaborate to develop SVP for type 1 diabetes

17-10-2014

US clinical-stage biopharma company Selecta Biosciences and JDRF have extended their joint research collaboration…

BiotechnologyDiabetesFranceResearchSanofiSelecta BiosciencesUSA

Aduro expands deal with Janssen to lung cancer; worth up to $817 million

Aduro expands deal with Janssen to lung cancer; worth up to $817 million

17-10-2014

Privately-held US cancer immunotherapy developer Aduro BioTech has entered into its second agreement…

Aduro BioTechBiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingOncologyResearch

Supply chain pressure can pose serious risk to pharma, experts argue

Supply chain pressure can pose serious risk to pharma, experts argue

16-10-2014

CPhI Worldwide, part of UBM Live’s Pharmaceutical Portfolio, has released the final part of its 2014…

BiotechnologyCPhI WorldwideGlobalPharmaceuticalResearch

Russia’s Generium to establish MabThera analogue production

16-10-2014

Generium Group of Companies, one of Russia’s largest producers of innovative drugs, has commissioned…

BiosimilarsBiotechnologyGeneriumMabTheraOncologyProductionRocheRussia

Big Pharma's control over the Russian state drug procurement tenders market slipping away, says Biocad

16-10-2014

Russian pharmaceutical companies are actively squeezing out foreign therapeutic manufacturers from the…

AcellBiaBiocadBiosimilarsBiotechnologyMabTheraMarkets & MarketingOncologyRituxanRocheRussia

Dendreon’s Provenge too expensive to be recommended, says NICE in draft guidance

Dendreon’s Provenge too expensive to be recommended, says NICE in draft guidance

16-10-2014

In preliminary draft guidance issued this morning the UK health costs watchdog the National Institute…

BiotechnologyDendreonOncologyPricingProvengeRegulationUK

Northwest Bio says DCVax-L hospital exemption program under way in Germany

Northwest Bio says DCVax-L hospital exemption program under way in Germany

15-10-2014

US biotech firm Northwest Biotherapeutics, which is developing DCVax personalized immune therapies for…

BiotechnologyDCVax-LGermanyNorthwest BiotherapeuticsOncologyRegulationResearch

Auspherix and Domainex collaborate for new drugs to combat antibiotic-resistance

Auspherix and Domainex collaborate for new drugs to combat antibiotic-resistance

15-10-2014

UK biotech firm Domainex and Australian drug discovery company Auspherix, a spin-out from the University…

AuspherixAuspherix PtyAustraliaBiotechnologyDomainexHealthLicensingPharmaceutical sciencesPharmacologyResearchUK

NICE preliminary guidance negative on Celgene’s pomalidomide for multiple myeloma

NICE preliminary guidance negative on Celgene’s pomalidomide for multiple myeloma

15-10-2014

UK medical costs watchdog the National Institute for Health and Care Excellence (NICE) has issued preliminary…

BiotechnologyCelgene Corp.ImnovidOncologyPricingRegulationUK

Smith & Nephew shares fall as HP802-247 living cell spray-on therapy fails to meet primary endpoint

Smith & Nephew shares fall as HP802-247 living cell spray-on therapy fails to meet primary endpoint

14-10-2014

Global medical technology business Smith & Nephew has found its Phase III study of HP802-247, a living…

Antibiotics and Infectious diseasesBiotechnologyHP802-247ResearchSmith & NephewUK

Trials commence on consortium's fully personalized cancer vaccines for glioblastoma

Trials commence on consortium's fully personalized cancer vaccines for glioblastoma

14-10-2014

A consortium funded by the European Union is to advance a new class of fully personalized cancer vaccines…

BioNTechBiotechnologyGermanyimmatics biotechnologiesOncologyResearch

Imaxio signs option for a license agreement with DKFZ

14-10-2014

French vaccine focussed biotech firm Imaxio has signed an option for a license agreement with the German…

Anti-viralsBiotechnologyImaxioLicensingResearch

Janssen files for EU approval of Stelara in pediatric plaque psoriasis

13-10-2014

Janssen-Cilag International says that a Type II Variation has been filed with the European Medicines…

BiotechnologyDermatologicalsEuropeInflammatory diseasesJanssen-CilagJohnson & JohnsonRegulationStelara

Bristol-Myers Squibb, Pharmacyclics and Janssen team up to test Opdivo and Imbruvica combination

Bristol-Myers Squibb, Pharmacyclics and Janssen team up to test Opdivo and Imbruvica combination

13-10-2014

US drug major Bristol-Myers Squibb, US-based biopharma company Pharmacyclics and Janssen Research and…

BiotechnologyBristol-Myers SquibbEuropeImbruvicaJanssenOncologyOpdivoPharmacyclics

1 to 25 of 2369 results

Parexel

Parexel

Back to top